Novartis

Novartis secures expanded approval for Pluvicto

AuntMinnie · 1 day ago

Novartis' Pluvicto gets US nod for hormone-sensitive prostate cancer

FirstWord Pharma · 1 day ago

PE Firm ChrysCapital Acquires Controlling Stake In Novartis India Limited

BW Disrupt · 3 days ago

Novartis India Ltd Announces Appointment of Vikas Gupta to CEO Role

marketscreener.com · 3 days ago

Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product

MedCity News · 3 days ago

ChrysCapital completes Novartis India Limited buy, taps former Alkem executive Vikas Gupta as CEO

Moneycontrol.com · 3 days ago

Novartis chart may soon 'complete a well-defined bullish reversal,' Cappelleri says

CNBC · 3 days ago

Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts

ChartMill · 4 days ago

Novartis AG (NVS) Stock Forecasts

Yahoo Finance · 4 days ago

Novartis Seeks To Halt Stada's Generic Heart Failure Drug

Law360 · 5 days ago

Denise Campbell of Novartis on the Shifting Conversations in Healthcare

Muse by Clio · 5 days ago

Anthropic’s life science plans; Novartis CEO on China deals; and more

Endpoints News · 8 days ago

How Novartis R&D is advancing the next breakthrough innovations

Novartis · 9 days ago

Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline

Yahoo Finance · 10 days ago

Novartis scraps mid-stage radiopharma asset as Pluvicto soars

BioSpace · 11 days ago

Novartis (SWX:NOVN) Is Pushing AI Deeper Into Drug Discovery

Yahoo Finance · 11 days ago

Novartis (SWX:NOVN) Is Pushing AI Deeper Into Drug Discovery

Yahoo Finance UK · 11 days ago

‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx deal

Fierce Biotech · 12 days ago

Novartis Profit Beats Estimates as Entresto Sales Plunge 50%

Yahoo Finance · 12 days ago

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

CNBC · 12 days ago